These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

481 related items for PubMed ID: 9420133

  • 1. Expression of interleukin (IL)-4 and IL-5 proteins in asthma induced by toluene diisocyanate (TDI).
    Maestrelli P, Occari P, Turato G, Papiris SA, Di Stefano A, Mapp CE, Milani GF, Fabbri LM, Saetta M.
    Clin Exp Allergy; 1997 Nov; 27(11):1292-8. PubMed ID: 9420133
    [Abstract] [Full Text] [Related]

  • 2. Is occupational asthma to diisocyanates a non-IgE-mediated disease?
    Jones MG, Floyd A, Nouri-Aria KT, Jacobson MR, Durham SR, Taylor AN, Cullinan P.
    J Allergy Clin Immunol; 2006 Mar; 117(3):663-9. PubMed ID: 16522468
    [Abstract] [Full Text] [Related]

  • 3. Role of intercellular adhesion molecule-1 in a murine model of toluene diisocyanate-induced asthma.
    Furusho S, Myou S, Fujimura M, Kita T, Yasui M, Kasahara K, Nakao S, Takehara K, Sato S.
    Clin Exp Allergy; 2006 Oct; 36(10):1294-302. PubMed ID: 17014439
    [Abstract] [Full Text] [Related]

  • 4. Effect of cessation of exposure to toluene diisocyanate (TDI) on bronchial mucosa of subjects with TDI-induced asthma.
    Saetta M, Maestrelli P, Di Stefano A, De Marzo N, Milani GF, Pivirotto F, Mapp CE, Fabbri LM.
    Am Rev Respir Dis; 1992 Jan; 145(1):169-74. PubMed ID: 1309964
    [Abstract] [Full Text] [Related]

  • 5. Immune mediators in a murine model for occupational asthma: studies with toluene diisocyanate.
    Matheson JM, Johnson VJ, Luster MI.
    Toxicol Sci; 2005 Mar; 84(1):99-109. PubMed ID: 15590890
    [Abstract] [Full Text] [Related]

  • 6. Increased expression of IL-16 immunoreactivity in bronchial mucosa after segmental allergen challenge in patients with asthma.
    Laberge S, Pinsonneault S, Varga EM, Till SJ, Nouri-Aria K, Jacobson M, Cruikshank WW, Center DM, Hamid Q, Durham SR.
    J Allergy Clin Immunol; 2000 Aug; 106(2):293-301. PubMed ID: 10932073
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Expression of mRNA for interleukin-5 in mucosal bronchial biopsies from asthma.
    Hamid Q, Azzawi M, Ying S, Moqbel R, Wardlaw AJ, Corrigan CJ, Bradley B, Durham SR, Collins JV, Jeffery PK.
    J Clin Invest; 1991 May; 87(5):1541-6. PubMed ID: 2022726
    [Abstract] [Full Text] [Related]

  • 11. Immunohistochemical characterization of the cellular infiltrate in airway mucosa of toluene diisocyanate (TDI)-induced asthma: comparison with allergic asthma.
    Park HS, Hwang SC, Nahm DH, Yim HE.
    J Korean Med Sci; 1998 Feb; 13(1):21-6. PubMed ID: 9539314
    [Abstract] [Full Text] [Related]

  • 12. Mast cells in the airway mucosa and rapid development of occupational asthma induced by toluene diisocyanate.
    Di Stefano A, Saetta M, Maestrelli P, Milani G, Pivirotto F, Mapp CE, Fabbri LM.
    Am Rev Respir Dis; 1993 Apr; 147(4):1005-9. PubMed ID: 8385428
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Expression of IL-4 and IL-5 mRNA and protein product by CD4+ and CD8+ T cells, eosinophils, and mast cells in bronchial biopsies obtained from atopic and nonatopic (intrinsic) asthmatics.
    Ying S, Humbert M, Barkans J, Corrigan CJ, Pfister R, Menz G, Larché M, Robinson DS, Durham SR, Kay AB.
    J Immunol; 1997 Apr 01; 158(7):3539-44. PubMed ID: 9120316
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. T cells and eosinophils in bronchial smooth muscle cell death in asthma.
    Solarewicz-Madejek K, Basinski TM, Crameri R, Akdis M, Akkaya A, Blaser K, Rabe KF, Akdis CA, Jutel M.
    Clin Exp Allergy; 2009 Jun 01; 39(6):845-55. PubMed ID: 19400895
    [Abstract] [Full Text] [Related]

  • 18. Prevention of IL-1 signaling attenuates airway hyperresponsiveness and inflammation in a murine model of toluene diisocyanate-induced asthma.
    Johnson VJ, Yucesoy B, Luster MI.
    J Allergy Clin Immunol; 2005 Oct 01; 116(4):851-8. PubMed ID: 16210060
    [Abstract] [Full Text] [Related]

  • 19. IL-17 is increased in asthmatic airways and induces human bronchial fibroblasts to produce cytokines.
    Molet S, Hamid Q, Davoine F, Nutku E, Taha R, Pagé N, Olivenstein R, Elias J, Chakir J.
    J Allergy Clin Immunol; 2001 Sep 01; 108(3):430-8. PubMed ID: 11544464
    [Abstract] [Full Text] [Related]

  • 20. Airway eosinophilia and expression of interleukin-5 protein in asthma and in exacerbations of chronic bronchitis.
    Saetta M, Di Stefano A, Maestrelli P, Turato G, Mapp CE, Pieno M, Zanguochi G, Del Prete G, Fabbri LM.
    Clin Exp Allergy; 1996 Jul 01; 26(7):766-74. PubMed ID: 8842549
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.